Jean-Pierre Majoral Selected Research

Phosphorus (Red Phosphorus)

11/2022	Engineered Stable Bioactive Per Se Amphiphilic Phosphorus Dendron Nanomicelles as a Highly Efficient Drug Delivery System To Take Down Breast Cancer In Vivo.
1/2022	Phosphorus dendron nanomicelles as a platform for combination anti-inflammatory and antioxidative therapy of acute lung injury.
6/2021	First-in-Class Phosphorus Dendritic Framework, a Wide Surface Functional Group Palette Bringing Noteworthy Anti-Cancer and Anti-Tuberculosis Activities: What Lessons to Learn?
1/2021	Facile Synthesis of Amphiphilic Fluorescent Phosphorus Dendron-Based Micelles as Antiproliferative Agents: First Investigations.
1/2021	Safe Polycationic Dendrimers as Potent Oral In Vivo Inhibitors of Mycobacterium tuberculosis: A New Therapy to Take Down Tuberculosis.
5/2020	Potent Anticancer Efficacy of First-In-Class CuII and AuIII Metaled Phosphorus Dendrons with Distinct Cell Death Pathways.
1/2020	Generation Dependent Effects and Entrance to Mitochondria of Hybrid Dendrimers on Normal and Cancer Neuronal Cells In Vitro.
1/2020	Revisiting Cationic Phosphorus Dendrimers as a Nonviral Vector for Optimized Gene Delivery Toward Cancer Therapy Applications.
11/2019	Metal-based phosphorus dendrimers as novel nanotherapeutic strategies to tackle cancers: A concise overview.
8/2017	Anti-Inflammatory Effect of Anti-TNF-α SiRNA Cationic Phosphorus Dendrimer Nanocomplexes Administered Intranasally in a Murine Acute Lung Injury Model.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Pierre Majoral Research Topics

Disease

26	Neoplasms (Cancer) 11/2022 - 09/2009
3	Breast Neoplasms (Breast Cancer) 11/2022 - 03/2019
3	Glioma (Gliomas) 05/2022 - 02/2018
3	Infections 09/2021 - 01/2019
3	Tuberculosis (Tuberculoses) 06/2021 - 07/2018
3	Neuroblastoma 01/2020 - 09/2013
3	Hemolysis 09/2015 - 07/2014
2	Glioblastoma (Glioblastoma Multiforme) 05/2022 - 02/2018
2	Acute Lung Injury 01/2022 - 08/2017
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 03/2012
2	Necrosis 05/2017 - 09/2013
1	Brain Neoplasms (Brain Tumor) 05/2022
1	Rabies (Hydrophobia) 01/2022
1	Influenza in Birds (Avian Flu) 01/2022
1	Cytokine Release Syndrome 09/2021
1	COVID-19 09/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2020
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2018
1	Leukemia 02/2018
1	Lung Diseases (Lung Disease) 08/2017
1	Ovarian Neoplasms (Ovarian Cancer) 05/2017
1	Spinal Cord Injuries (Spinal Cord Injury) 11/2015
1	Pathologic Processes 05/2015
1	Peripheral Nerve Injuries 12/2013
1	Pneumonia (Pneumonitis) 05/2013
1	Parkinson Disease (Parkinson's Disease) 03/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2013
1	Synucleinopathies 03/2013

Drug/Important Bio-Agent (IBA)

36	Dendrimers (Dendrons)IBA 11/2022 - 06/2004
20	Phosphorus (Red Phosphorus)IBA 11/2022 - 06/2004
8	Small Interfering RNA (siRNA)IBA 05/2022 - 05/2015
7	Pharmaceutical PreparationsIBA 11/2022 - 05/2015
5	GoldIBA 10/2021 - 06/2016
4	dendronIBA 11/2022 - 01/2021
3	ViologensIBA 01/2020 - 03/2013
3	CopperIBA 06/2019 - 04/2013
2	MicellesIBA 11/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 11/2022 - 02/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 09/2013
2	CytokinesIBA 01/2022 - 09/2021
2	Antiviral Agents (Antivirals)IBA 09/2021 - 05/2015
2	PrionsIBA 01/2020 - 06/2004
2	Poly(amidoamine)IBA 01/2019 - 09/2018
2	Photosensitizing Agents (Photosensitizers)IBA 01/2016 - 05/2015
1	src-Family KinasesIBA 05/2022
1	Messenger RNA (mRNA)IBA 05/2022
1	EnzymesIBA 05/2022
1	Antitubercular AgentsIBA 06/2021
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2021
1	Streptomycin (Streptomycin Sulfate)FDA Link 01/2021
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2021
1	DexpramipexoleIBA 07/2020
1	benzothiazoleIBA 07/2020
1	Riluzole FDA LinkGeneric 07/2020
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2020
1	carbosilaneIBA 01/2020
1	Drug CarriersIBA 01/2020
1	MetalsIBA 11/2019
1	PolymersIBA 07/2019
1	LigandsIBA 06/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	pyridineIBA 01/2019
1	ElementsIBA 01/2019
1	Antisense OligonucleotidesIBA 01/2019
1	PolyethyleneimineIBA 11/2018
1	GadoliniumIBA 11/2018
1	IonsIBA 11/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2018
1	ferric oxide (iron oxide)IBA 03/2018
1	CyclodextrinsIBA 02/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2017
1	Cisplatin (Platino)FDA LinkGeneric 05/2017
1	Glutathione Transferase (Glutathione S-Transferase)IBA 10/2016
1	polydopamineIBA 06/2016
1	titanium dioxide (Titania)FDA Link 09/2015
1	Ammonium CompoundsIBA 09/2015
1	AntioxidantsIBA 05/2015
1	Contrast MediaIBA 05/2015
1	Human Serum Albumin FDA LinkGeneric 04/2015
1	Ethacrynic Acid (Etacrynic Acid)FDA Link 03/2015
1	SilicatesIBA 07/2014
1	Nerve Growth Factors (Neurotrophins)IBA 12/2013
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 05/2013
1	SynucleinsIBA 03/2013
1	tau Proteins (tau Protein)IBA 03/2012
1	Peptides (Polypeptides)IBA 03/2012

Therapy/Procedure

16	Therapeutics 11/2022 - 12/2013
4	Drug Therapy (Chemotherapy) 11/2022 - 09/2018
3	Precision Medicine 10/2021 - 06/2016
2	Radiotherapy 10/2021 - 01/2019
1	Photochemotherapy (Photodynamic Therapy) 03/2019
1	Intranasal Administration 08/2017
1	Photothermal Therapy 06/2016